Aptorum Group posts wider net loss and negative cash flow for the six months ended June 30, 2026, compared to the prior year.
Aptorum Group reported a GAAP loss per share of $1.60 for the first half of 2026, reflecting a deeper net loss compared to the same period last year. Net loss attributable to Niki BioSolutions, Inc. reached $1,326,004, up from $441,780 in 2025.
The company also disclosed a total net loss of $1,307,300, negative working capital of $2,475,418, and net operating cash outflow of $1,553,720 for the period. These figures highlight financial strain amid ongoing operations.
No immediate market reaction was detailed in the release.